tiprankstipranks
Trending News
More News >
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
UK Market

Circassia Pharmaceuticals (NIOX) Financial Statements

Compare
12 Followers

Circassia Pharmaceuticals Financial Overview

Circassia Pharmaceuticals's market cap is currently £283.84M. The company's EPS TTM is p0.008; its P/E ratio is 77.27; and it has a dividend yield of 136.69%. Circassia Pharmaceuticals is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 41.80M£ 36.80M£ 31.30M£ 27.90M£ 23.90M
Gross Profit£ 30.20M£ 26.50M£ 22.20M£ 19.00M£ 16.30M
Operating Income£ 7.70M£ 4.60M£ 1.80M£ -4.30M£ -17.30M
EBITDA£ 12.20M£ 8.60M£ 15.20M£ 2.90M£ -9.10M
Net Income£ 3.70M£ 10.70M£ 16.10M£ 3.60M£ -33.50M
Balance Sheet
Cash & Short-Term Investments£ 10.90M£ 19.90M£ 19.40M£ 12.60M£ 7.40M
Total Assets£ 68.40M£ 91.50M£ 98.50M£ 86.40M£ 103.10M
Total Debt£ 1.50M£ 1.10M£ 1.00M£ 1.30M£ 1.60M
Net Debt£ -9.40M£ -18.80M£ -18.40M£ -11.30M£ -5.80M
Total Liabilities£ 8.90M£ 7.70M£ 16.60M£ 19.60M£ 37.00M
Stockholders' Equity£ 59.50M£ 83.80M£ 81.90M£ 66.80M£ 66.10M
Cash Flow
Free Cash Flow£ 16.20M£ 11.30M£ 6.60M£ 1.20M£ -24.40M
Operating Cash Flow£ 17.20M£ 11.60M£ 6.70M£ 1.40M£ -23.90M
Investing Cash Flow£ -1.00M£ -300.00K£ -100.00K£ -200.00K£ -500.00K
Financing Cash Flow£ -25.10M£ -10.50M£ -500.00K£ 4.10M£ 4.30M
Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History

Circassia Pharmaceuticals Debt to Assets

Circassia Pharmaceuticals Cash Flow

Circassia Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis